The presence of human chorionic gonadotropin in large bowel cancers was studied immunohistochemically using an immunoperoxidase technique. HCG-positive tumour cells were present in 42 of 194 adenocarcinomas examined (22.0% of colon cancer and 21.2% of rectal cancers). On histological grading, the hCG-positive rate tended to rise as the degree of differentiation decreased. HCG was detected more frequently in cancers invading the total bowel wall (27%) than in those invading the partial wall (17.1%). Lymph node, liver or peritoneal metastases were present more frequently in hCG-positive tumours than in hCG-negative tumours. Furthermore, there was an intimate correlation between the presence of hCG-positive tumour cells and CEA doubling times in nine cases with untreated liver metastasis. The survival rate for patients with tissue hCG-positive cells was lower than for those with hCG-negative tumours. Thus, the presence of tissue hCG in colorectal cancers may be a biological marker of prognostic significance. © The Macmillan Press Ltd., 1989.
CITATION STYLE
Yamaguchi, A., Ishida, T., Nishimura, G., Kumaki, T., Katoh, M., Kosaka, T., … Miyazaki, I. (1989). Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis. British Journal of Cancer, 60(3), 382–384. https://doi.org/10.1038/bjc.1989.289
Mendeley helps you to discover research relevant for your work.